Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset

October 27, 2016 updated by: Steffen Desch, MD, University of Leipzig
The purpose of this study is to examine the benefit of thrombus aspiration in patients with ST-elevation myocardial infarction presenting late after symptom onset.

Study Overview

Study Type

Interventional

Enrollment (Actual)

152

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leipzig, Germany, 04289
        • University of Leipzig Heart Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ST-elevation myocardial infarction >12 and <48 hours after symptom onset
  • age 18 to 90 years
  • informed consent

Exclusion Criteria:

  • prior fibrinolysis
  • severe comorbidities with limited life expectancy
  • pregnancy
  • patient unable to give informed consent
  • participation in another trial
  • contraindications for heparin, aspirin or thienopyridines
  • contraindications for cardiac magnetic resonance examination

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: thrombus aspiration
Manual thrombus aspiration with dedicated catheter (Export, Medtronic Inc. Minneapolis, Minnesota, USA)
manual thrombus aspiration catheter to be used during percutaneous coronary intervention
No Intervention: no thrombus aspiration

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Microvascular obstruction (cardiac magnetic resonance imaging)
Time Frame: 1-4 days after randomization
1-4 days after randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2011

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

May 1, 2015

Study Registration Dates

First Submitted

June 20, 2011

First Submitted That Met QC Criteria

June 21, 2011

First Posted (Estimate)

June 23, 2011

Study Record Updates

Last Update Posted (Estimate)

October 28, 2016

Last Update Submitted That Met QC Criteria

October 27, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Myocardial Infarction

Clinical Trials on manual thrombus aspiration (Export catheter, Medtronic Inc. Minneapolis, Minnesota, USA)

Subscribe